Physician profile
Stephen B Potts
NPI 1851371116
$561.29
in general payments reported to CMS, 2019-2025
14 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $11.06 · 2021: $26.85 · 2022: $183 · 2023: $32.05 · 2024: $69.41 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $176.31 | 2021-2024 | |
| Intersect Ent, INC. | $82.51 | 2019-2020 | |
| Masimo Corporation | $73.09 | 2024-2025 | Set and Rainbow Set |
| Vertex Pharmaceuticals Incorporated | $41.50 | 2025 | |
| Glaxosmithkline, LLC. | $30.58 | 2023-2024 | Nucala |
| Aerin Medical INC. | $29.67 | 2019-2025 | |
| Karl Storz Endoscopy-America | $27.57 | 2019 | |
| Stryker Corporation | $24.90 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $20.55 | 2022 | |
| Merck Sharp & Dohme LLC | $15.87 | 2023 | |
| Medtronic, INC. | $14.08 | 2025 | Propel |
| Hospira, INC. | $13.30 | 2022 | |
| Kaleo, INC. | $11.36 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.